This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Iproteos S.l., Universität De Barcelona, Accure Therapeutics, S.l.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2025
Title: Teresa Tarragó Clua: Innovator in Pharmaceutical Chemistry
Introduction
Teresa Tarragó Clua is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of 3 patents, her work focuses on innovative solutions for cognitive disorders.
Latest Patents
Among her latest patents, one notable invention is the compound 1-[1-(4-benzyloxy-3,5-difluoro-benzoyl)-4-fluoro-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile. This invention relates to derivatives that exhibit pharmacological activity and outlines processes for their preparation, as well as their use in therapy and prophylaxis of cognitive disorders. Another significant patent is for 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives, which also have pharmacological activity and are aimed at addressing cognitive disorders.
Career Highlights
Teresa has worked with esteemed institutions such as the Universitat de Barcelona and Iproteos S.L. Her research and innovations have positioned her as a key figure in her field, contributing to advancements in pharmaceutical applications.
Collaborations
Throughout her career, Teresa has collaborated with notable professionals, including Roger Prades Cosano and Ernest Giralt Lledó. These collaborations have further enriched her research and development efforts.
Conclusion
Teresa Tarragó Clua's contributions to pharmaceutical chemistry through her innovative patents highlight her dedication to improving therapeutic options for cognitive disorders. Her work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile